🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

FDA selects tech companies for regulatory pilot program

Published 09/26/2017, 02:19 PM
© Reuters.  FDA selects tech companies for regulatory pilot program
GOOGL
-
AAPL
-
JNJ
-
005930
-
GOOG
-
FIT
-
  • The U.S. Food and Drug Administration selects 9 tech companies for a pilot program that could allow them to avoid some regulations on health products.
  • The Pre-Cert pilot program allows members to go through an advanced audit of software and facilities and, upon passing, have an easier path to approval and market.
  • Selected companies include Apple (NASDAQ:AAPL), Fitbit (NYSE:FIT), Samsung (KS:005930), Verily Life Sciences (GOOG, GOOGL)
  • , Johnson & Johnson (NYSE:JNJ), and Roche.
  • Projects up for potential audit include the Apple Watch’s potential for detecting heart abnormalities and Verily and Novartis’ contact lenses that work as continuous glucose monitors
  • Previously: Asymco: Apple Watch sold $4.9B in past year (Sept. 26)
  • Now read: 300 Billion Reasons To Buy Apple


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.